Volume Beat, Profit Miss: The Case of Suzlon's Margin Squeeze
Suzlon delivered its highest-ever Q1 revenue (+22% YoY) but profitability fell 5.9% despite prior guidance of stable-to-improving margins. The call reveals a structural shift management isn't calling out: EPC business is rising fast, and it's diluting gross margins faster than ASP gains can offset.
₹3,829 Cr
+22.3% YoY; highest Q1 execution
₹305 Cr
-5.9% YoY; NPM 7.9% vs prior stable guidance
15.6%
₹595 Cr; below 17–18% guided range
₹40–50 Cr
Cited as primary margin driver; called year-long
On paper, Suzlon crushed its revenue target—the highest Q1 delivery (506 MW) in company history, ₹3,829 Cr revenue, exactly forecast PAT of ₹305 Cr. But the profit number masks the real story. Management guided for 'stable to improving WTG margins' in prior calls; Q1 delivered 15.6% EBITDA margin, 130 basis points below the 17–18% floor they promised. Profitability fell 5.9% despite a 22% revenue surge—a troubling inversion that the call blamed on ₹40–50 Cr in upfront Suzlon 2.0 capex and supply chain drag. Neither explanation is wrong, but together they expose a third culprit: the EPC business is growing structurally, and it's eroding gross margins faster than the headline ASP story suggests.
Where the margin miss came from
The call reconciles the EBITDA gap with one-time costs—new Puducherry facility, Suzlon 2.0 tech investment (S175, S163), exports marketing. That's ₹40–50 Cr. But even with those backed out, the quarter still signals structural headwinds. The EPC (Engineering, Procurement, Construction) business surged from 22% of revenue to 32% in a single quarter, lifting ASP from ₹5.6 Cr/MW to ₹6.3 Cr/MW. Higher ASP sounds good; but EPC is a lower-margin business than pure supply contracts. So while revenue-per-MW climbed, gross margin compressed because Suzlon is selling more lower-margin EPC and less high-margin pure turbine supply. Management didn't break out the gross margin explicitly, but the implication is clear: ₹40–50 Cr of capex drag plus EPC dilution plus supply chain deferral all hit EBITDA simultaneously in Q1. The question for H2 and FY27 is whether any of these three reverse decisively.
Revenue 22% YoY growth, highest Q1 execution.
Delivered ₹3,829 Cr, +22.3% YoY, 506 MW delivery (vs 117 MW prior year Q1).
Supported
PAT ₹305 Cr shows strong profitability despite supply chain.
PAT ₹305.2 Cr delivered exactly as forecast, but down 5.9% YoY; margin 7.9% compressed vs prior stable guidance.
Contradicted
EBITDA ₹595 Cr, margins stable at 17–18%.
EBITDA ₹595 Cr, but margin 15.6%. Call blamed ₹40–50 Cr one-time costs; did not acknowledge EPC mix dilution as structural.
Overstated
ASP improved from ₹5.6 Cr/MW to ₹6.3 Cr/MW from project mix.
ASP rose 12.5%, but EPC share jumped 22% → 32%, offsetting gross margin gains with lower-margin business.
Overstated (gains masked by mix)
1,257 MW erected inventory ready to convert, unlocking H2 uplift.
Figure provided; seasonality claim (H1 35–40%, H2 60–65%) historically valid; but only 269 MW (5.3%) commissioned in Q1.
Supported (dependent on H2 execution)
DevCo 600+ MW in 4 months, 60% of new business, validates model.
Order book 6.1 GW + ~1 GW in first 4 months FY27 aligns. DevCo shift real and de-risks pure supply; early validation sound.
Supported
What changed on this call
EPC mix accelerated to 32% (from 22%): strategic shift to higher-ASP project contracts, but margin-dilutive. Not flagged as persistent structural headwind.
Suzlon 2.0 capex quantified: ₹40–50 Cr/Q upfront drag; called 'year-long journey,' not one-time. Impacts FY27 guide credibility.
Supply chain vulnerability materialized: Middle East tensions deferred 10–20% of Q1 (50–100 MW). Geopolitical risk now explicit.
EBITDA margin guidance reaffirmed at 17–18% ± 0.5%, but Q1 achieved 15.6%. Call claims H2 operating leverage recovery; no specific bridge provided.
Order book diversification: DevCo model 60% of new orders; de-risks pure supply but introduces land/receivable concentration risk.
The street's verdict: Price, flows, and positioning
The market opened Suzlon down 1.19% on day 1 of the result and has held that line, fading only marginally by day 3 to −0.02%. At current price ₹48.1, the stock sits 21.79% below its all-time high of ₹61.5, testing oversold territory (RSI 28). More tellingly, the stock is now below all major moving averages (SMA20 ₹51.66, SMA50 ₹54.47, SMA200 ₹51.24), signalling a broken near-term structure. The good news: FII ownership held steady at 23.85% with only +12 bps inflow, and promoter holding at 11.73% without selling. This suggests institutions are not panicking or exiting; they are waiting. The stock has recovered 25.95% off the 52-week low of ₹38.19, but from here it looks like a 'show me' story. The day-1 response tells us the market initially signalled disappointment on the margin miss, which aligns with the fundamental read: strong execution on volume, but profitability fell despite guidance. Credibility on the recovery story hinges on whether Suzlon can prove that the margin gap narrows in H2.
The Q&A reveals what management will and won't defend
Analysts pressed hard on three points. First, the margin weakness despite higher ASP: one analyst directly asked whether EBIT per MW fell even though ASP rose. Management attributed this to (a) Suzlon 2.0 capex drag, (b) supply chain, (c) AMS vs RE Solutions segment mix, but stopped short of naming EPC as a go-forward structural diluter. Second, domestic WTG pricing under pressure from lower utility-scale orders. When asked directly if pricing has softened due to the ~50 GW drop in utility tendering, management deflected, saying 'wind has traction, it's a volume game.' No reassurance on pricing durability. Third, BESS partnerships (FY31 target 3.1 GW)—still in 'discussion phase,' no partners named, no terms. These dodges matter because they suggest management is aware of structural headwinds but framing them as temporary. Confidence score: 6/10. The call scored well on specifics (order book, capex, one-time costs) but was evasive on competitive pricing, margin structure, and new-product execution risk.
Highest-ever Q1 delivery (506 MW); 23% revenue growth vs industry backdrop of lower utility ordering.
Market-leading order book 6.1 GW; DevCo model 600+ MW in 4 months de-risks pure supply model.
1,257 MW erected inventory awaiting commissioning; if H2 seasonal 60–65% realization holds, margin recovery plausible.
Suzlon 2.0 capex (5-MW, exports, tech) positioned for next-cycle growth; ₹700 Cr FY27 capex plan ± ₹100 Cr defined.
PAT down 5.9% YoY despite revenue +22%; profitability not keeping pace with growth signals structural headwind.
EBITDA margin 15.6% vs 17–18% guided; 130 bps miss blamed on one-time costs, but EPC dilution is structural and unacknowledged.
EPC mix 22% → 32% in one quarter; if trend continues to 40%+ and margins don't recover, gross margin erosion becomes persistent.
Supply chain deferred 10–20% of Q1; geopolitical risk now visible. If recurring, H2 recovery narrative breaks.
Repowering 25 GW opportunity still unproven; pilots promised by year-end but no confirmed pipeline yet.
BESS partnerships (FY31 3.1 GW target) only in discussion phase; no partners, terms, or timeline disclosed.
Domestic WTG pricing under pressure from lower utility demand; management deflected on durability.
DevCo working capital intensive (₹500 Cr cap); interest expense up 30% YoY despite lower market rates.
Margin recovery is unproven; operating leverage narrative hedged.
HighQ1 missed 17–18% EBITDA guide by 130 bps. Call claims H2 will recover via 60–65% seasonal COD realization + ₹40–50 Cr capex anniversary, but gave no bridge and no H2 specific guidance. If delivered EBITDA stays at 15.6–16% for full year, guidance will be materially missed and credibility hit.
EPC business mix dilutes gross margin; ASP gains mask deterioration.
HighEPC jumped 22% → 32% in one quarter; management called it 'strategic' but didn't flag margin dilution as structural. If EPC becomes 40%+ of revenue and gross margin erodes further, earnings-per-MW will compress even with higher ASP. This is the quiet earnings driver not being acknowledged.
Supply chain disruptions could recur; geopolitical risk now visible.
HighMiddle East tensions deferred 10–20% of Q1 (50–100 MW). If this recurs in H2 (Syria escalation, Houthi blockade, etc.), the 1,257 MW erected inventory won't convert on schedule and margin recovery narrative breaks. No hedging mentioned.
Suzlon 2.0 capex payback uncertain; S175/S163 ramp unproven.
MediumS175 domestic only at pilot order stage; first delivery year-end/FY28. S163 international needs 18–24 months to seed. Capex payback timeline is 12–18 months per call, but execution risk is material if customer demand doesn't materialize or ramp is delayed.
Repowering 25 GW opportunity lacks confirmed pipeline.
MediumCalled a go-to opportunity but no confirmed orders. Call promised 'pilots and orders by year-end'; if they don't materialize, strategic narrative is weakened. Timing also unclear—is repowering a FY27 or FY28+ driver?
Domestic WTG pricing under structural pressure; market share exposure high.
MediumUtility-scale ordering down ~50 GW vs 2 years ago. When analyst asked if domestic WTG pricing has softened, management dodged ('wind has traction, volume game'). If pure WTG realization contracts, Suzlon's market-leading 6.1 GW order book may realize at lower ASP than modeled.
DevCo model working capital intensive; receivable/land concentration risk.
Medium₹500 Cr DevCo cap, ₹200–300 Cr already invested. Receivable days may lengthen if customer advances are delayed or land prices rise. Interest expense up 30% YoY signals WC is already elevated. If DevCo ROI falls short or conversion cycle extends, cash returns disappointing.
BESS partnerships only in discussion; FY31 3.1 GW target unsubstantiated.
LowCalled a key component of FY31 10 GW strategy, but partnerships still in 'discussion phase' with no partners named. If no deal closes by end FY27, FY31 ambition becomes only 7.5 GW wind (no solar/BESS), reducing addressable market and upside.
1 · H2 EBITDA margin trajectory and operating leverage recovery
The crux of the story. If Q2–Q4 EBITDA margin averages ≥17%, management's 'temporary dislocation' narrative holds and the stock re-rates. If margins stay 15.5–16.5%, the EPC dilution and capex drag are structural, guidance is missed, and credibility drops. Track: (a) sequential EBITDA margin Q2 vs Q1, (b) management's H2 guidance if offered, (c) gross margin by segment if disclosed.
2 · Supply chain normalization and 1,257 MW erected inventory conversion
Q1 delivered only 269 MW out of 1,257 MW erected (5.3% realization). If Q2–Q3 sees delivery ramp to 40–50% of erected inventory, H2 60–65% seasonal story is tracking. If conversion stays slow (10–20%), geopolitical/logistics risk is persistent and H2 guidance is at risk. Track: quarterly delivery, COD, and backlog of erected-but-not-commissioned machines.
3 · S175 domestic and S163 international order pipeline and first shipments
FY27 execution on Suzlon 2.0 capex depends on order validation. S175 has one pilot order; if no additional orders materialize by Q3, or first shipment slips to FY28, payback timeline extends and credibility on 'no long investments' claim deteriorates. S163 international seeding 18–24 months out. Track: number of S175 orders booked, S163 pre-orders or customer LOIs, shipment timelines.
4 · EPC and DevCo mix as % of revenue; gross margin by segment
Critical to understanding if margin recovery is real or just a reversion to seasonal norm. If EPC + DevCo reach 50% of revenue and gross margin falls to single digits, ASP gains are a mirage. Track: segment revenue splits (WTG vs EPC vs DevCo), gross margin %, and EBITDA margin by segment if disclosed.
5 · Repowering pilots, orders, and qualification timeline
Call promised 'pilots and orders by year-end'; this is a binary test of management credibility on new growth drivers. If nothing materializes by Q3 FY27, repowering is pushed to FY28+ and FY31 10 GW target becomes harder to hit (narrowed to wind + DevCo only). Track: pilot project announcements, customer names, order book impact.
Suzlon delivered a strong Q1 on revenue (+22% YoY, 506 MW delivery) but the profit picture is muddier. PAT fell 5.9% YoY despite the headline growth, and EBITDA margin (15.6%) missed guidance (17–18%) by 130 basis points. Management blamed ₹40–50 Cr in Suzlon 2.0 capex and supply chain drag—both real—but neither tells the full story. The EPC business jumped from 22% to 32% of revenue in a single quarter, and that mix shift is structurally diluting gross margins. ASP climbed ₹0.7 Cr/MW, but it's a mirage because the company is selling lower-margin EPC contracts.
The market's day-1 move (−1.19%) captured this ambiguity perfectly: strong volume execution but profitability didn't follow. The stock remains oversold (RSI 28) and below all key moving averages, but FII hasn't panicked. This is a 'show me' setup. The next two quarters are make-or-break on the margin recovery narrative. If EBITDA margin stays at 15.6–16% and supply chain disruptions recur, guidance is missed and the stock re-rates lower. If Suzlon clears 17%+ margins by Q4 and ships the 1,257 MW erected inventory on H2 seasonal schedule, the long-term case (10 GW FY31, Suzlon 2.0 capex payback) becomes credible again.
Rating: Hold. The franchise is good, but the transition is murky. Conviction improves only when margins recover and H2 execution proves the 'temporary dislocation' claim. The number to track from here is sequential EBITDA margin. Watch for Q2 FY27 earnings (likely Oct 2026). Until then, the stock is fairly valued as a 'what-if' on margin recovery—not cheap enough to buy on the dip, not broken enough to exit. Existing holders should stay; new entry points below ₹42–44 (support at SMA200 ₹51.24) would be more attractive if margin recovery remains unproven.
Suzlon Q1: revenue +23% YoY but PAT dips to ₹305 Cr on margin squeeze, misses Street
PAT -5.89% YoY · revenue +22.52% · margins compressing · miss vs street
₹3,819.36 Cr
+22.52% YoY
₹305.22 Cr
-5.89% YoY
7.9%
-2.3pp YoY
₹0.22
Suzlon opened FY27 with strong volume-led topline growth but a year-on-year profit decline. Consolidated revenue was ₹3,819 Cr (+22.5% YoY) on highest-ever Q1 deliveries of 506 MW (+14% YoY), broadly in line with Street's ₹3,740–3,890 Cr range. But EBITDA was flat YoY at ₹595 Cr (vs ₹599 Cr) and PAT slipped 5.9% to ₹305 Cr — both below consensus, which had modelled ~₹700 Cr EBITDA and ~₹390–490 Cr PAT. PBT fell 15% YoY to ₹389 Cr. The steep sequential drop (revenue −30%, PAT −73% QoQ) is largely seasonal: Q4 is Suzlon's strongest quarter and last quarter's ₹1,114 Cr PAT was flattered by a ₹284 Cr deferred-tax credit and a ₹70 Cr exceptional gain, so the YoY read is the cleaner one.
Q1 FY-2027 vs prior quarters
The gap between topline growth and falling profit is a margin story. EBITDA margin compressed ~360bps YoY to 15.6% (from 19.2%) and net margin fell to 8.0% from 10.4%. CFO Rahul Jain attributed the softness to temporary logistics disruptions from the geopolitical situation, certain strategic investments, and a change of scope and segment mix. The mix is the biggest swing — EPC's share of the order book rose to 32% (from 22% in Q1 FY26), and EPC carries structurally lower margins (WTG contribution margin 23.4%). Below EBITDA, higher depreciation (₹106 Cr vs ₹70 Cr) and net finance cost (₹100 Cr vs ₹70 Cr) squeezed PBT further, and a non-cash deferred-tax (DTA) charge of ₹83.7 Cr took PAT down. There were no exceptional items this quarter.
The stock went into the print at ₹51.16, down 10.6% over the past month of trading.
Management expressed strong confidence in continued growth for FY27 and FY28, anticipating industry installations to reach 8-10 GW in FY27 and 15 GW by FY30-'31. Suzlon expects to benefit from this robust demand, with a healthy order book and a strategic shift towards EPC contracts expected to accelerate order closures
— This quarter: met
Against management's prior-call guidance (strong FY27/28 growth, 8–10 GW industry installations, healthy order book, EPC shift), the growth engine is on track: the order book rose to ~6.1 GW (from 5.9 GW at Mar'26, ~6,135 MW including Waaree's 201.6 MW post-June), 84% from PSU/C&I, with ~1 GW of new orders YTD FY27 including Tata Power (400 MW EPC), Sunsure (105 MW) and Waaree. But the 'stable-to-improving WTG margins' part of that guidance did not materialise this quarter. The balance sheet stayed net cash at ₹2,322 Cr, and the board also approved a wholly-owned Singapore subsidiary to expand international wind/OMS. Standalone told the same directional story — PAT ₹306 Cr, down ~12% YoY. The rest of FY27 hinges on whether the volume ramp (1,257 MW erected but pending commissioning) and a normalising mix can pull margins back up.
W1
EBITDA margin recovery: whether 15.6% (down from 19.2% YoY) rebounds as EPC-heavy scope mix normalises — management guided stable-to-improving WTG margins
W2
Order-book conversion: 6.1 GW book with EPC shift expected to accelerate closures from June 2026 — watch inflow and execution ramp
W3
Commissioning ramp: 1,257 MW erected but pending commissioning against 269 MW commissioned in Q1 — watch H2 revenue conversion
Clean limited-reviewed statement; consolidated is primary. otherIncome = other operating income + other income. No exceptional items this quarter (prior Q4 had ₹70cr gain; standalone prior periods had large exceptionals). PAT held back by ~360bps EBITDA margin compression, higher depreciation (₹106cr vs ₹70cr) & finance cost (₹134cr vs ₹103cr), and a non-cash deferred-tax/DTA charge of ₹83.7cr. Q1 EPS not annualised.
Strong volumes masked by margin squeeze; recovery hinges on H2 execution
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met revenue guide (+22% YoY), PAT exactly forecast (₹305 Cr). Margin miss vs. prior guidance of stable WTG margins (delivered 15.6% vs. 17-18% target). Blamed temporary factors; credibility hinges on H2 recovery and operating leverage.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Suzlon delivered on revenue (₹3,829 Cr, +22%) but profitability collapsed (PAT -5.9% YoY to ₹305 Cr, NPM 7.9%), confounding prior guidance of stable-to-improving margins. One-time Suzlon 2.0 capex (₹40-50 Cr) plus supply chain drag blamed, but execution risk on FY27 17-18% EBITDA target and new products (S175, S163, exports) remains material.
₹3829.1 Cr
Revenue · +22.3% YoY₹305.2 Cr
Reported PAT · −5.9% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue 23% YoY growth, highest Q1 execution
METDelivered ₹3,829 Cr (22.3% YoY); 506 MW delivery recorded
PAT ₹305 Cr shows strong profitability despite supply chain
MISSDelivered ₹305.2 Cr but down 5.9% YoY; margin 7.9% vs prior expectations of stable/improving
EBITDA ₹595 Cr, margins stable at 17-18%
OVERSTATEDEBITDA margin 15.6% (₹595/₹3,829), below guided 17% floor; one-time costs of ₹40-50 Cr blamed
1,257 MW erected inventory ready to convert, unlocking H2 uplift
METSpecific figure provided in transcript; seasonality claim (H1 35-40%, H2 60-65%) supports recovery narrative
ASP improvement from ₹5.6 Cr to ₹6.3 Cr/MW due to project mix
OVERSTATEDEPC share expanded 22% → 32%, lower-margin business; net ASP gains offset by gross margin dilution
DevCo orders 600+ MW in 4 months, 60% of new business
METSpecific claim made; aligns with shift to land-backed development model; still early validation needed
Earnings quality
What changed since the last call
EPC mix accelerates to 32% (from 22%)
NewStrategic shift to EPC driving higher ASP (₹5.6 → ₹6.3 Cr/MW) and DevCo model revenue (60% of new orders); margin structure changing faster than prior guidance assumed.
Suzlon 2.0 capex upfront costs ₹40-50 Cr/Q
DowngradePrior call assumed Suzlon 2.0 ramp without quantified drag. Q1 revealed ₹40-50 Cr in new plants, tech investment, exports, reducing EBITDA by 1-2 percentage points.
Supply chain vulnerability materialized
DowngradeMiddle East tensions deferred 10-20% of deliveries (50-100 MW). Prior guidance assumed smooth execution; geopolitical risk now visible.
EBITDA margin guidance tightened to 17-18%
NeutralReaffirming historical 17-18% range but Q1 achieved 15.6%; call blamed one-time costs and claimed H2 operating leverage recovery; credibility hinges on execution.
Order book diversification to DevCo 60% mix
Upgrade600+ MW DevCo orders in 4 months confirms market appetite for land-backed model; de-risks pure supply-based business.
The Q&A
Analysts pressed hard on margin compression (EBIT/MW decline despite higher ASP), supply chain timing, working capital vs. EPC mix, and payback timelines on capex. Management defended with one-time costs and operating leverage rebound; didn't concede structural margin headwinds. Q&A score: 6/10 (answered revenue/capex/order specifics but dodged WTG pricing domestically, market share gains post-ALMM, Foundry utilization, and BESS partner details).
Revenue recognition & commissioning gap — Balasubramanian, Arihant Capital
AnsweredGap continues; seasonality H1 35-40% vs H2 60-65% applies. 1,257 MW erected machines ready; erection completion will improve COD going forward.
S175 & capex payback — Balasubramanian, Arihant Capital
PartialInternational 18-24 months to seed, domestic S175 first order in place for year-end/next-year deliveries. Capex payback 12-18 months as volumes ramp; not long investments.
Order book composition & credit — Balasubramanian, Arihant Capital
PartialPricing accounts for payable days, well-covered. Mix evolving; PSUs have larger targets, C&I are repeat customers. Sharp focus on receivables management.
EBIT margin decline on per-MW basis — Mohit Kumar, ICICI Securities
PartialEBITDA flattish (₹599 Cr Q1 FY26 vs ₹595 Cr Q1 FY27) due to (a) Suzlon 2.0 investments upfront, (b) supply chain drag + operating leverage, (c) AMS segment mix shift (higher margin) vs RE Solutions.
ALMM implementation & market share — Mohit Kumar, ICICI Securities
DodgedSuzlon fully compliant, well-positioned vs import-dependent competitors. Second part—can connect separately.
Fixed cost at Q4 levels despite lower volume — Sumit Kishore, Axis Capital
PartialOne-time costs baked into Q1. Year-long investments in exports, DevCo, others. EBITDA margin 17-18% ± 1-2% should hold; H2 operating leverage will improve.
DevCo EPC 602 MW—advances & execution timeline — Sumit Kishore, Axis Capital
PartialSimilar terms to past contracts, but land & connectivity ready for faster implementation. All advances similar nature as past; value accretive.
DevCo working capital & land investment — Prakhar Porwal, Ambit Capital
AnsweredCurrent sales from advanced DevCo sites already invested in land; advances unlock soon as site progress. Year 3-5 orders in pipeline, slightly different strategy, not yet announced but team working on them.
Suzlon 2.0 capex breakdown — Prakhar Porwal, Ambit Capital
AnsweredNew plants, technology for new prototypes (domestic & international), marketing in international markets. All inevitable for growth strategy.
Repowering in India — Prakhar Porwal, Ambit Capital
Partial25 GW repowering potential in India. Working on S88-120 platform. Pilots and confirmed orders expected before end of year. Minister's wind fleet report identifying sites.
One-time cost quantification — Sweta Jain, Anand Rathi
Answered₹40-50 Cr across subheads. Year-long journey, not just Q1, as we ramp volumes should not have such major impact full year.
Suzlon 2.0 revenue timing — Sweta Jain, Anand Rathi
PartialOperating 17-18% margin, can give/take 0.5%. Strong Q1 delivery (506 MW), highest ever June series, 23% revenue, 12% RR, 130% COD growth. 1,250 MW erected waiting commissioning—value accretive going forward.
Foundry & Forgings utilization — Sweta Jain, Anand Rathi
DodgedImpacted by geopolitical issues (Gulf crisis, customer hit). Trying to increase export share. Distinct 3 segments (foundry, forging, bearing); more customer pipeline. Coming quarters will show strategy panning out.
Foreign holding cap — Satpal Singh Khanuja, Ishaan Ventures
AnsweredNo cap. Can't place a cap; that's the rule.
Installed capacity ramp (4.5 → 7.5 GW) — Satpal Singh Khanuja, Ishaan Ventures
PartialWon't give a number, but if capacity shifts to 5-MW, much higher. Order book mostly S144 3-series; transition takes time.
Material consumed increase driver — Satpal Singh Khanuja, Ishaan Ventures
AnsweredEPC share went from 22% to 32%—substantial shift. Material consumed naturally higher with EPC business.
ASP sustainability with EPC mix — Raj Shah, Enam AMC
PartialEPC share up 22-32%; scope increased. This is judgmental, ASPs fairly good shape. As project business higher, will see ASP in that range.
RE AMS margin sustainability — Raj Shah, Enam AMC
AnsweredActually 43% this quarter, elevated. Should be higher 30s, 38-39%. Timing issue sometimes.
Interest expense spike — Amit Bhinde, Axis Capital
AnsweredRevenue up 23%, working capital utilization flat-to-higher drives interest up. But overall rates commanded from market have come down—positive change. Tax charges are deferred tax asset rundown, mostly non-cash.
DevCo investment and interest impact — Amit Bhinde, Axis Capital
AnsweredOverall cash utilization position. DevCo ₹200-300 Cr ongoing; higher rates lower than year-start. Overall working capital led to higher interest; rates improving.
Capex plan and capacity additions — Amit Bhinde, Axis Capital
AnsweredCapex ₹700 Cr ± ₹100 Cr (unchanged). For 5-MW series, need blade factories including AI-enabled ones. Investing into future rather than just current 4.5 GW.
Gross margin driver (mix vs commodity) — Nikhil Abhyankar, UTI MF
AnsweredAMS (high margin) vs RE Solutions (supply) mix has impacted. Some one-time costs as well. Largely mix impact, correct.
DevCo cap and scalability — Priyesh Babariya, Mahindra Manulife MF
Answered₹250 Cr is very old number. Even in Suzlon 2.0 strategy, discussed as ₹500 Cr cap. If change, will communicate. That's the guardrail.
EPC working capital impact — Neil Ostwal, PGIM India
PartialNo negative impact from EPC. Working various tracks to improve cycle; significant reduction in numbers per investor presentation.
BESS partnership specifics — Neil Ostwal, PGIM India
PartialDiscussion phase with various partners; few encouraging rounds. Should close partnerships and arrangements in next couple of months. Target 3.1 GW by FY31; hybrid controllers in pilot orders.
Pricing vs global competitors — Abhishek, Motilal Oswal
PartialNot competing on price, competing on value/energy/delivery. Will price at par with local players. Some customers already have Suzlon fleet managed by ops team.
Domestic WTG pricing and INR impact — Abhishek, Motilal Oswal
DodgedWind traction good. Pricing more or less same. Volume game; as ramp up volumes, unit cost comes down. INR depreciation offset by cost optimization.
FY31 10 GW sales capacity path — Nitin Kaushik, Afin Capital
AnsweredFY31 is 5 years out. 10 GW includes wind + solar + BESS (75-25 split = 7.5 GW wind). Migrate to 5-MW series in same plants; existing 4.5 GW capacity shifts to higher output. Enough transition time.
Deferred delivery timing in H2 — Nilkhil Toptani, Kizuna
PartialH1/H2 seasonality: 35-40% vs 60-65%. That trend continues; cannot assume all in Q2.
Contribution margin on EPC mix — Nilkhil Toptani, Kizuna
AnsweredNot EPC vs non-EPC; look at RE Solutions vs RE AMS. AMS higher margin (service nature). As WTG volumes ramp, mix changes, slightly lower margin overall.
Guidance
FY27 sustained growth trajectory; FY31 10 GW RE sales (75-25 wind-solar-BESS split)
MediumQuantified long-term target but dependent on DevCo scaling, S175/S163 ramp, repowering execution. No explicit FY27 revenue number given; relying on 25% CAGR claim over 5 years.
FY27 EBITDA margin 17-18% (±0.5%), vs Q1 delivered 15.6%
LowReaffirmed despite Q1 miss; blamed ₹40-50 Cr one-time Suzlon 2.0 capex and supply chain drag. Operating leverage recovery in H2 expected but not quantified; credibility hinges on execution.
FY27 capex ₹700 Cr ± ₹100 Cr for new plants, 5-MW series, blade factories (AI-enabled)
HighReiterated prior guidance. Separate from DevCo investment (₹500 Cr cap, currently ₹200-300 Cr). All capex aimed at future product ramp and export footprint.
Risks the call surfaced
Supply chain / Geopolitical
High10-20% of Q1 deliveries (50-100 MW) deferred due to fuel availability and crane/transport vehicle shortages. Could recur if tensions escalate.
Margin compression vs guidance
HighQ1 EBITDA margin 15.6% vs guided 17-18% floor. PAT down 5.9% YoY despite revenue +22% growth. Signals structural headwinds (EPC mix, capex drag) not just temporary.
EPC business mix shift
MediumEPC share jumped 22% → 32% in one quarter, driving ASP up (₹5.6 → ₹6.3 Cr/MW) but compressing gross margin. If trend continues, gross margin erosion could offset ASP gains.
New product execution risk
MediumS175 5-MW domestic only at pilot order stage (first delivery year-end/FY28). S163 international 18-24 mo seeding; export markets unproven. Repowering 25 GW opportunity promised but no confirmed orders yet.
DevCo working capital intensity
MediumDevCo investment ₹200-300 Cr of ₹500 Cr plan; requires upfront land buying, connectivity setup, customer advances. If land prices rise or customer advances delay, cash burn increases and IRR pressure.
Competitive pricing pressure
MediumUtility-scale wind orders fallen ~50 GW vs 2 years back. Analyst questioned WTG pricing sustainability; management deflected, claiming 'wind has traction' and 'volume game.' If pricing softens for pure WTG (ex-EPC), realization decline risk.
BESS partnership execution
LowBESS partnerships only in 'discussion phase'; no partners named or terms disclosed. FY31 target (5 years out) requires rapid scaled-up ramp if partnerships close soon.
Management
Score 6/10. Moderate transparency. Quantified ₹40-50 Cr one-time costs and order book size, but deflected on market share gains post-ALMM, domestic WTG pricing trajectory, and BESS partner identities. Used 'separate discussion' and 'can connect later' to avoid specifics. Mixed track record. Hit Q1 revenue (₹3,829 Cr, +22% YoY) and PAT (₹305.2 Cr exactly forecast), but profitability declined -5.9% YoY despite growth. Prior guidance of 'stable to improving WTG margins' not achieved; margins compressed 15.6% vs 17-18% target. Credited temporary factors (supply chain, capex drag) but execution on Suzlon 2.0 still unproven.
1 · Q2-Q3 FY27
1,257 MW erected turbines commissioned (H2 seasonal ramp 60-65% vs H1 35-40%)
2 · End of FY27
S175 5-MW domestic deliveries begin (first order confirmed); repowering pilot orders expected
3 · Q3-Q4 FY27
S163 export seeding accelerates (18-24 mo international ramp from now); BESS partnerships close
One-time Suzlon 2.0 capex (₹40-50 Cr) plus supply chain drag blamed, but execution risk on FY27 17-18% EBITDA target and new products (S175, S163, exports) remains material.